Who
Paul T. Lehr
General Counsel, Secretary
Company insider
Files Form 4 as: General Counsel, Secretary, Longeveron.
In numbers
- Trades disclosed
- 43
- Buys
- 1
- Sells
- 0
- Bought
- $5,845
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 20 Jul 2021
- Last trade
- 1 Oct 2026
- Last filed
- 5 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 Oct 2026filed 5 Oct 2026 | LGVN LongeveronBiotechnology | SEC FORM 4 Code F | $5,8352,253 at $2.59 | filing |
| 19 Aug 2026filed 21 Aug 2026 | LGVN LongeveronBiotechnology | SEC FORM 4 Code A | —286,000 at $0.00 | filing |
| 19 Aug 2026filed 21 Aug 2026 | LGVN LongeveronBiotechnology | SEC FORM 4 Code A | —286,000 at $0.00 | filing |
| 1 Jul 2026filed 6 Jul 2026 | LGVN LongeveronBiotechnology | SEC FORM 4 Code F | $9,58313,143 at $0.7291 | filing |
| 1 Jul 2026filed 6 Jul 2026 | LGVN LongeveronBiotechnology | SEC FORM 4 Code F | $9,59413,143 at $0.73 | filing |
| 1 May 2026filed 5 May 2026 | LGVN LongeveronBiotechnology | SEC FORM 4 Code A | —250,000 at $0.00 | filing |
| 1 May 2026filed 5 May 2026 | LGVN LongeveronBiotechnology | SEC FORM 4 Code A | —250,000 at $0.00 | filing |
| 1 Apr 2026filed 3 Apr 2026 | LGVN LongeveronBiotechnology | SEC FORM 4 Code F | $6,2845,611 at $1.12 | filing |
| 1 Apr 2026filed 3 Apr 2026 | LGVN LongeveronBiotechnology | SEC FORM 4 Code F | $6,2845,611 at $1.12 | filing |
| 2 Jan 2026filed 6 Jan 2026 | LGVN LongeveronBiotechnology | SEC FORM 4 Code F | $4,1236,952 at $0.593 | filing |
| 2 Jan 2026filed 6 Jan 2026 | LGVN LongeveronBiotechnology | SEC FORM 4 Code F | $4,1026,952 at $0.59 | filing |
| 1 Oct 2025filed 3 Oct 2025 | LGVN LongeveronBiotechnology | SEC FORM 4 Code F | $3,6594,944 at $0.74 | filing |
| 15 Jul 2025filed 17 Jul 2025 | LGVN Longeveronoption or derivative · Biotechnology | SEC FORM 4 Code A | —34,000 at $0.00 | filing |
| 15 Jul 2025filed 17 Jul 2025 | LGVN LongeveronBiotechnology | SEC FORM 4 Code A | —102,000 at $0.00 | filing |
| 1 Jul 2025filed 3 Jul 2025 | LGVN LongeveronBiotechnology | SEC FORM 4 Code F | $1,9991,562 at $1.28 | filing |
| 23 Jun 2025filed 25 Jun 2025 | LGVN LongeveronBiotechnology | SEC FORM 4 Code A | —163,043 at $0.00 | filing |
| 23 Jun 2025filed 25 Jun 2025 | LGVN LongeveronBiotechnology | SEC FORM 4 Code F | $74K64,158 at $1.15 | filing |
| 1 Apr 2025filed 3 Apr 2025 | LGVN LongeveronBiotechnology | SEC FORM 4 Code F | $2,3991,599 at $1.50 | filing |
| 2 Jan 2025filed 6 Jan 2025 | LGVN LongeveronBiotechnology | SEC FORM 4 Code F | $2,1571,205 at $1.79 | filing |
| 1 Oct 2024filed 3 Oct 2024 | LGVN LongeveronBiotechnology | SEC FORM 4 Code F | $1,861990 at $1.88 | filing |
News
No headline names them, or the companies they trade most, lately.